Showing posts with the label HealthShow all
FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer After 42% Trial Response Rate
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer After 42% Trial Response Rate

The U.S. Food and Drug Administration granted accelerated approval on November 5, 2026, to Johnson & …

Noureldin November 06, 2026
Read more
FDA Approves Ilumya for Psoriatic Arthritis Following Phase 3 Trials
Health

FDA Approves Ilumya for Psoriatic Arthritis Following Phase 3 Trials

The U.S. Food and Drug Administration (FDA) has approved Ilumya (tildrakizumab-asmn) for adults with active p…

Noureldin November 04, 2026
Read more
Novartis Heart Drug Trial Failure Raises Questions About Lp(a) Treatments
Health

Novartis Heart Drug Trial Failure Raises Questions About Lp(a) Treatments

Novartis's experimental cardiovascular drug pelacarsen failed to demonstrate a reduction in major cardiovasc…

Noureldin November 03, 2026
Read more
Judge Blocks Trump Medicaid Rule Limiting Work Exemptions for Chronically Ill Patients
Health

Judge Blocks Trump Medicaid Rule Limiting Work Exemptions for Chronically Ill Patients

XML A federal judge blocked a Trump administration rule on October 29, 2026, that would have required cer…

Noureldin October 30, 2026
Read more
Retatrutide Beats Ozempic on Weight Loss and Blood Sugar in Phase 3 Diabetes Trial
Health

Retatrutide Beats Ozempic on Weight Loss and Blood Sugar in Phase 3 Diabetes Trial

Eli Lilly's experimental diabetes drug retatrutide produced greater average reductions in blood sugar and bod…

Noureldin October 29, 2026
Read more
Load More That is All